Brooks Laboratories Ltd Quarterly Results

Gross Sales

25.51

23.32

20.52

20.79

17.93

Excise Duty

0

0

0

0

0

Net Sales

25.51

23.32

20.52

20.79

17.93

Other Operating Income

0

0

0

0

0

Other Income

7.15

0.62

0.03

0.2

0.07

Total Income

32.66

23.94

20.54

20.99

18

Total Expenditure

22.39

24.57

22.01

24.2

19.85

PBIDT

10.28

-0.63

-1.46

-3.21

-1.85

Interest

0.3

0.26

0.28

0.32

0.16

PBDT

9.98

-0.9

-1.75

-3.53

-2.01

Depreciation

0.39

0.39

0.38

0.43

0.4

Minority Interest Before NP

0

0

0

0

0

Tax

0

0.18

0

0

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

9.58

-1.46

-2.13

-3.96

-2.41

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

9.58

-1.46

-2.13

-3.96

-2.41

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

9.58

-1.46

-2.13

-3.96

-2.41

EPS (Unit Curr.)

3.25

-0.54

-1.75

-1.51

-0.94

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

29.46

29.46

26.25

26.25

26.25

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

40.29

-2.7

-7.11

-15.44

-10.31

PBDTM(%)

39.12

-3.85

-8.52

-16.97

-11.21

PATM(%)

37.55

-6.26

-10.38

-19.04

-13.44